CYTEK BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.22 USD | +0.32% |
|
+7.99% | -31.80% |
| 03-20 | Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing | MT |
| 03-19 | Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance | MT |
Chart calendar Cytek Biosciences, Inc.
ab0e94d372caba.LdM9FJtXXmhafCmCFfL-yH2Ejtodz7Jws6dkKjQF9OI.fJpbYcEWOxkqTx_AIcrHqg737Yton8U9gfcxXmRHmptonnci-C0uJ20jTg~0a1aa4f42a02324013fd1d1bf88e7f96
Upcoming events on Cytek Biosciences, Inc.
Past events on Cytek Biosciences, Inc.
| 2024-03-06 11:10 | TD Cowen Health Care Conference |
| 2024-03-04 14:15 | Raymond James Institutional Investors Conference |
| 2024-02-28 17:05 | Q4 2023 Earnings Release |
| 2024-02-28 17:00 | Q4 2023 Earnings Call |
| 2024-02-12 | BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference |
| 2024-01-11 11:15 | JPMorgan Healthcare Conference |
| 2023-11-28 13:30 | Piper Sandler Healthcare Conference |
| 2023-11-07 16:30 | Q3 2023 Earnings Call |
| 2023-11-07 16:05 | Q3 2023 Earnings Release |
| 2023-10-04 | Roadshow |
| 2023-10-01 13:00 | International Clinical Cytometry Meeting |
| 2023-09-28 09:00 | European Society for Clinical Cell Analysis Conference |
| 2023-09-27 13:15 | Cantor Global Healthcare Conference |
| 2023-09-13 16:15 | Morgan Stanley Global Healthcare Conference |
| 2023-08-16 10:00 | UBS MedTech, Tools and Genomics Summit |
| 2023-08-08 16:30 | Q2 2023 Earnings Call |
| 2023-08-08 16:05 | Q2 2023 Earnings Release |
| 2023-06-14 18:20 | Goldman Sachs Global Healthcare Conference |
| 2023-06-14 14:00 | Annual General Meeting |
| 2023-05-09 16:30 | Q1 2023 Earnings Call |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 128 125 2.02% | 164 166 -1.43% | 193 191 1.34% | 208 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 17,5 18,2 -3.47% | 21,2 26,6 -20.55% | 13,7 8,83 55.14% | 21,4 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | 16,7 13,6 22.23% | -1,80 7,91 -122.82% | -26,8 -28,4 5.84% | -17,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 5,95 7,20 -17.39% | 1,26 6,94 -81.86% | -14,6 -18,2 19.71% | -7,70 |
|
Net income Million USD | Released Forecast Spread | 19,4 | 4,44 5,70 -22.05% | 2,58 7,61 -66.14% | -11,3 -16,4 30.78% | -7,30 |
|
EPS USD | Released Forecast Spread | 0,00 | 0,05 0,10 -50% | 0,02 0,06 -64.71% | -0,09 -0,13 28.57% | -0,04 |
| Announcement Date | 02/07/21 | 23/02/22 | 28/02/23 | 28/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 38,9 36,4 6.81% | 35,1 33,0 6.26% | 40,2 39,6 1.34% | 40,5 43,3 -6.49% | 48,3 50,2 -3.82% | 37,1 47,1 -21.33% | 49,7 45,7 8.71% | 48,0 55,5 -13.48% | 58,6 56,6 3.6% | 43,6 | 49,3 | 52,3 | 62,4 | 51,8 |
|
EBITDA Million USD | Released Forecast Spread | 1,54 2,23 -30.73% | 3,72 1,29 188.15% | 11,0 6,09 79.96% | 1,59 | 3,31 | 4,91 | 11,6 | 4,16 | ||||||
|
EBIT Million USD | Released Forecast Spread | 5,24 3,91 33.84% | -2,36 | -0,89 | 1,36 1,74 -21.93% | 0,08 5,39 -98.44% | -12,2 0,46 -2747.77% | -9,13 -2,31 -294.77% | 1,16 1,19 -2.47% | 0,93 -0,73 227.5% | -9,20 | -6,29 | -4,29 | 2,39 | -7,15 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,45 1,50 -69.73% | -3,30 -1,80 -83.5% | -1,40 0,00 - | 1,85 0,40 362.5% | 4,11 4,25 -3.2% | -9,04 0,30 -3113.33% | -6,60 -0,38 -1637.81% | -4,19 5,00 -183.7% | 5,18 2,80 85% | -6,99 | -4,30 | -2,40 | 4,55 | -4,64 |
|
Net income Million USD | Released Forecast Spread | 0,23 1,30 -82.69% | -2,02 -1,80 -12.28% | -0,60 -0,30 -99.33% | 1,67 -0,10 1766% | 3,53 3,40 3.79% | -6,81 0,30 -2369% | -4,39 -0,30 -1345.8% | -6,46 4,00 -261.4% | 6,32 2,30 174.87% | -6,99 | -4,16 | -2,08 | 4,78 | -4,47 |
|
EPS USD | Released Forecast Spread | 0,00 0,01 -83% | -0,02 -0,01 -50.04% | 0,00 0,00 - | 0,01 0,01 49.93% | 0,03 0,03 -9.99% | -0,05 0,01 -600% | -0,03 -0,01 -125.06% | -0,05 0,03 -300% | 0,04 0,01 300% | -0,05 | -0,03 | -0,01 | 0,03 | -0,03 |
| Announcement Date | 23/02/22 | 11/05/22 | 10/08/22 | 09/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 07/11/23 | 28/02/24 | - | - | - | - | - |
| 2024-05-06 | QUANTERIX CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 01:00 | SIEMENS HEALTHINEERS AG: Q2 2024 Earnings Release |
| 2024-05-07 06:50 | WATERS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-07 | CLASSYS INC.: Q1 2024 Earnings Release |
| 2024-05-07 | STANDARD BIOTOOLS INC.: Q1 2024 Earnings Release |
| 2024-05-08 01:00 | CARL ZEISS MEDITEC AG: Q2 2024 Earnings Release |
| 2024-05-08 16:05 | CYTEK BIOSCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-08 | JEISYS MEDICAL INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 | OLYMPUS CORPORATION: Q4 2024 Earnings Release |
| 2024-05-12 | NIHON KOHDEN CORPORATION: Q4 2023 Earnings Release |
Past sector events for Cytek Biosciences, Inc.
| 2024-05-02 16:05 | LEMAITRE VASCULAR, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:05 | ILLUMINA, INC.: Q1 2024 Earnings Release |
| 2024-05-02 16:01 | HOLOGIC, INC.: Q2 2024 Earnings Release |
| 2024-05-02 07:00 | BRUKER CORPORATION: Q1 2024 Earnings Release |
| 2024-05-02 07:00 | INMODE LTD.: Q1 2024 Earnings Release |
| 2024-04-30 16:05 | TRANSMEDICS GROUP, INC.: Q1 2024 Earnings Release |
| 2024-04-30 06:20 | GE HEALTHCARE TECHNOLOGIES INC.: Q1 2024 Earnings Release |
| 2024-04-29 06:00 | REVVITY, INC.: Q1 2024 Earnings Release |
| 2024-04-29 01:00 | PHILIPS NV: Q1 2024 Earnings Release |
| 2024-04-26 | SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CTKB Stock
- Calendar Cytek Biosciences, Inc.
